Antiepileptics in Migraine Prophylaxis
By: Krishna Tamakuwala, PharmD candidate c/o 2023 Migraines are characterized by episodes of head pain that are often throbbing…
Drug Information Questions: Vaccines are Drugs Too
By: Aisa Mrkulic, Maria Michael and Svetlana Bachayev, PharmD Candidates c/o 2022 With the surge of Coronavirus Disease 2019…
Connecting the Dots: Ankylosing Spondylitis and Heart Disease
By: Jennifer Galvet, PharmD Candidate c/o 2024 Ankylosing spondylitis (AS) is a systemic inflammatory condition that primarily affects a…
FDA approves Vibegron (Gemtesa®) for the Treatment of Patients with Symptoms of Overactive Bladder
By: Arya Firoozan, PharmD Candidate c/o 2023 Overactive bladder (OAB) is a condition that causes a sudden and frequent…
Correlation of Salt-Intake and Hypertension
By: Jordan Plair, PharmD Candidate c/o 2022 and Marina Beshara, PharmD Candidate c/o 2022 While the focus over the…
Desmopressin Challenge for Von Willebrand’s Disease in the Setting of Myasthenia Gravis
By: Oluwafemi Popoola, PharmD Candidate c/o 2021, SUNY Binghamton School of Pharmacy & Pharmaceutical Sciences A patient with past…
Emerging Frontiers in Multiple Myeloma Pharmacotherapy
By: Nishanth Viswanath, PharmD Candidate c/o 2022 Multiple myeloma (MM) is a hematological malignancy characterized by an accumulation and…
Pharmaceutical Breakthrough for the Treatment of Duchenne Muscular Dystrophy
By: Rubab Hassan, PharmD Candidate c/o 2022 Duchenne muscular dystrophy (DMD) is a genetic disorder that causes muscle degeneration…
Bamlanivimab for the treatment of COVID-19
By: Daniela Farzadfar, PharmD,PGY-1 Resident at Long Island Jewish Medical Center In March 2020, the World Health Organization (WHO)…
Insulin Monitoring System for Pediatric patients
By: Lyana Sayilar, PharmD Candidate c/o 2022 On August 31, 2020, the FDA approved the first automated diabetes management…